Adolax 20 mg/10 mg tablete s produljenim oslobađanjem
| Name | Adolax 20 mg/10 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-345330993 |
| Active Substance | oksikodonklorid naloksonklorid dihidrat |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 20 mg oksikodonklorida što odgovara 18 mg oksikodona i 10 mg naloksonklorida kao 10,9 mg naloksonklorid dihidrata što odgovara 9 mg naloksona |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija
TAD Pharma Gmbh, Cuxhaven, Njemačka |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 14.06.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/41 |
| Registration Number | 381-12-01/38-21-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to special medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N02AA55 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
